Dr. Gribbin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
145 Michigan St NE
Ste 3100
Grand Rapids, MI 49503Phone+1 616-954-9800Fax+1 616-954-2116
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 1985 - 1988
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1981 - 1984- University of Illinois College of MedicineClass of 1981
Certifications & Licensure
MI State Medical License 1986 - 2026
IL State Medical License 1982 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Start of enrollment: 2011 Nov 01
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsEffect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.Mitchell Reitsma, John Fox, Pierre Vanden Borre, Matthew Cavanaugh, Yakov Chudnovsky
Journal of Managed Care & Specialty Pharmacy. 2019-01-11 - 19 citations90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesVincent J. Picozzi, Ramesh K. Ramanathan, Maeve A. Lowery, Allyson J. Ocean, Edith P. Mitchel
European Journal of Cancer. 2015-09-01 - 2 citationsAlveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 TherapyLaura E. Zyczynski, Jonathan B. McHugh, Thomas E. Gribbin, Scott M. Schuetze
Case Reports in Oncological Medicine. 2015-07-22
Press Mentions
End-of-Life Talks May Finally Overcome PoliticsAugust 30th, 2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
